Rehovot, Israel

David Margel

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Margel - Innovator in Cancer Diagnosis

Introduction

David Margel is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of cancer diagnosis, particularly focusing on bladder and prostate cancers. His innovative approach utilizes non-invasive urinary tests to enhance the accuracy of cancer detection.

Latest Patents

David Margel holds a patent for "Urinary biomarkers for cancer diagnosis." This invention is directed towards improving the diagnosis of bladder cancer (BC) and prostate cancer (CaP). The patent outlines a method that employs urinary levels of heat shock proteins and anti-inflammatory cytokines as biomarkers, providing a simple and effective diagnostic tool characterized by high sensitivity and specificity.

Career Highlights

Throughout his career, David has worked with prominent organizations, including Yeda Research and Development Company Ltd. and Mor Research Applications Ltd. His work in these companies has contributed to advancements in medical research and diagnostics.

Collaborations

David has collaborated with esteemed colleagues such as Irun R Cohen and Meirav Pevsner-Fischer. These partnerships have furthered his research and development efforts in the field of cancer diagnostics.

Conclusion

David Margel's innovative work in cancer diagnosis exemplifies the impact of research and invention in improving healthcare outcomes. His contributions continue to pave the way for advancements in non-invasive diagnostic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…